{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:27:38Z","timestamp":1767054458365,"version":"3.48.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-025-02080-7","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T03:14:09Z","timestamp":1764040449000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Distinguishing IDH-mutant astrocytomas from IDH-wildtype glioblastomas using qualitative and quantitative MRI features: a WHO CNS5 study"],"prefix":"10.1186","volume":"25","author":[{"given":"Linlin","family":"Meng","sequence":"first","affiliation":[]},{"given":"Xiaolin","family":"Wu","sequence":"additional","affiliation":[]},{"given":"Kai","family":"Su","sequence":"additional","affiliation":[]},{"given":"Hai","family":"Zhong","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"2080_CR1","doi-asserted-by":"publisher","first-page":"102427","DOI":"10.1016\/j.nicl.2020.102427","volume":"28","author":"S Regnery","year":"2020","unstructured":"Regnery S, Behl NGR, Platt T, Weinfurtner N, Windisch P, Deike-Hofmann K, et al. Ultra-high-field sodium MRI as biomarker for tumor extent, grade and IDH mutation status in glioma patients. Neuroimage Clin. 2020;28:102427.","journal-title":"Neuroimage Clin"},{"key":"2080_CR2","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41571-020-00447-z","volume":"18","author":"M Weller","year":"2021","unstructured":"Weller M, van den Bent M, Preusser M, Le Rhun E, Tonn JC, Minniti G, et al. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat Rev Clin Oncol. 2021;18:170\u201386.","journal-title":"Nat Rev Clin Oncol"},{"key":"2080_CR3","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23:1231\u201351.","journal-title":"Neuro Oncol"},{"key":"2080_CR4","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/imm.13649","volume":"169","author":"F Tang","year":"2023","unstructured":"Tang F, Wang D-W, Xi C, Yang J-Z, Liu Z-Y, Yu D-H, et al. Local and systemic effects of IDH mutations on primary glioma patients. Immunology. 2023;169:503\u201314.","journal-title":"Immunology"},{"key":"2080_CR5","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41388-021-02056-1","volume":"41","author":"G Alzial","year":"2022","unstructured":"Alzial G, Renoult O, Paris F, Gratas C, Clavreul A, Pecqueur C. Wild-type isocitrate dehydrogenase under the spotlight in glioblastoma. Oncogene. 2022;41:613\u201321.","journal-title":"Oncogene"},{"key":"2080_CR6","first-page":"885","volume":"13","author":"KA Choate","year":"2024","unstructured":"Choate KA, Pratt EPS, Jennings MJ, Winn RJ, Mann PB. IDH mutations in glioma: Molecular, Cellular, Diagnostic, and clinical implications. Biology (Basel). 2024;13:885.","journal-title":"Biology (Basel)"},{"key":"2080_CR7","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/NEN.0b013e31822713f0","volume":"70","author":"M Preusser","year":"2011","unstructured":"Preusser M, W\u00f6hrer A, Stary S, H\u00f6ftberger R, Streubel B, Hainfellner JA. Value and limitations of immunohistochemistry and gene sequencing for detection of the IDH1-R132H mutation in diffuse glioma biopsy specimens. J Neuropathol Exp Neurol. 2011;70:715\u201323.","journal-title":"J Neuropathol Exp Neurol"},{"key":"2080_CR8","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1093\/neuonc\/now256","volume":"19","author":"H Zhou","year":"2017","unstructured":"Zhou H, Valli\u00e8res M, Bai HX, Su C, Tang H, Oldridge D, et al. MRI features predict survival and molecular markers in diffuse lower-grade gliomas. Neuro Oncol. 2017;19:862\u201370.","journal-title":"Neuro Oncol"},{"key":"2080_CR9","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.3174\/ajnr.A2950","volume":"33","author":"JA Carrillo","year":"2012","unstructured":"Carrillo JA, Lai A, Nghiemphu PL, Kim HJ, Phillips HS, Kharbanda S, et al. Relationship between tumor enhancement, edema, IDH1 mutational status, MGMT promoter methylation, and survival in glioblastoma. AJNR Am J Neuroradiol. 2012;33:1349\u201355.","journal-title":"AJNR Am J Neuroradiol"},{"key":"2080_CR10","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.3174\/ajnr.A5171","volume":"38","author":"Z Xing","year":"2017","unstructured":"Xing Z, Yang X, She D, Lin Y, Zhang Y, Cao D. Noninvasive assessment of IDH mutational status in world health organization grade II and III Astrocytomas using DWI and DSC-PWI combined with conventional MR imaging. AJNR Am J Neuroradiol. 2017;38:1138\u201344.","journal-title":"AJNR Am J Neuroradiol"},{"key":"2080_CR11","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ejrad.2019.03.003","volume":"114","author":"H Hyare","year":"2019","unstructured":"Hyare H, Rice L, Thust S, Nachev P, Jha A, Milic M, et al. Modelling MR and clinical features in grade II\/III Astrocytomas to predict IDH mutation status. Eur J Radiol. 2019;114:120\u20137.","journal-title":"Eur J Radiol"},{"key":"2080_CR12","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1097\/RCT.0000000000001456","volume":"47","author":"H Uetani","year":"2023","unstructured":"Uetani H, Azuma M, Khant ZA, Watanabe Y, Kudo K, Kadota Y, et al. Importance of age and Noncontrast-Enhancing tumor as biomarkers for isocitrate Dehydrogenase-Mutant glioblastoma: A multicenter study. J Comput Assist Tomogr. 2023;47:659\u201365.","journal-title":"J Comput Assist Tomogr"},{"key":"2080_CR13","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1007\/s00330-019-06548-3","volume":"30","author":"M Kim","year":"2020","unstructured":"Kim M, Jung SY, Park JE, Jo Y, Park SY, Nam SJ, et al. Diffusion- and perfusion-weighted MRI radiomics model May predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma. Eur Radiol. 2020;30:2142\u201351.","journal-title":"Eur Radiol"},{"key":"2080_CR14","doi-asserted-by":"publisher","first-page":"6751","DOI":"10.1007\/s00330-024-10708-5","volume":"34","author":"X Wang","year":"2024","unstructured":"Wang X, Shu X, He P, Cai Y, Geng Y, Hu X, et al. Ultra-high b-value DWI accurately identifies isocitrate dehydrogenase genotypes and tumor subtypes of adult-type diffuse gliomas. Eur Radiol. 2024;34:6751\u201362.","journal-title":"Eur Radiol"},{"key":"2080_CR15","doi-asserted-by":"publisher","first-page":"640738","DOI":"10.3389\/fonc.2021.640738","volume":"11","author":"J Zhang","year":"2021","unstructured":"Zhang J, Peng H, Wang Y-L, Xiao H-F, Cui Y-Y, Bian X-B, et al. Predictive role of the apparent diffusion coefficient and MRI morphologic features on IDH status in patients with diffuse glioma: A retrospective Cross-Sectional study. Front Oncol. 2021;11:640738.","journal-title":"Front Oncol"},{"key":"2080_CR16","doi-asserted-by":"publisher","first-page":"110318","DOI":"10.1016\/j.mri.2024.110318","volume":"117","author":"P \u015aledzi\u0144ska-Bebyn","year":"2025","unstructured":"\u015aledzi\u0144ska-Bebyn P, Furtak J, Bebyn M, Bartoszewska-Kubiak A, Serafin Z. Investigating glioma genetics through perfusion MRI: rCBV and rCBF as predictive biomarkers. Magn Reson Imaging. 2025;117:110318.","journal-title":"Magn Reson Imaging"},{"key":"2080_CR17","doi-asserted-by":"publisher","first-page":"110314","DOI":"10.1016\/j.mri.2024.110314","volume":"117","author":"D Li","year":"2025","unstructured":"Li D, Hu W, Ma L, Yang W, Liu Y, Zou J, et al. Deep learning radiomics nomograms predict isocitrate dehydrogenase (IDH) genotypes in brain glioma: A multicenter study. Magn Reson Imaging. 2025;117:110314.","journal-title":"Magn Reson Imaging"},{"key":"2080_CR18","doi-asserted-by":"publisher","first-page":"109736","DOI":"10.1016\/j.compbiomed.2025.109736","volume":"186","author":"B Sacli-Bilmez","year":"2025","unstructured":"Sacli-Bilmez B, Bas A, Er\u015fen Danyeli A, Yakicier MC, Pamir MN, \u00d6zduman K, et al. Detecting IDH and TERTp mutations in diffuse gliomas using 1H-MRS with attention deep-shallow networks. Comput Biol Med. 2025;186:109736.","journal-title":"Comput Biol Med"},{"key":"2080_CR19","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00062-024-01465-5","volume":"35","author":"K Amador","year":"2025","unstructured":"Amador K, Kniep H, Fiehler J, Forkert ND, Lindner T. Evaluation of an Image-based classification model to identify glioma subtypes using arterial spin labeling perfusion MRI on the publicly available UCSF glioma dataset. Clin Neuroradiol. 2025;35:151\u20138.","journal-title":"Clin Neuroradiol"},{"key":"2080_CR20","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s00234-022-03072-y","volume":"65","author":"NS Cho","year":"2023","unstructured":"Cho NS, Hagiwara A, Sanvito F, Ellingson BM. A multi-reader comparison of normal-appearing white matter normalization techniques for perfusion and diffusion MRI in brain tumors. Neuroradiology. 2023;65:559\u201368.","journal-title":"Neuroradiology"},{"key":"2080_CR21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159\u201374.","journal-title":"Biometrics"},{"key":"2080_CR22","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1148\/radiol.2462062166","volume":"246","author":"KA B\u00fcsing","year":"2008","unstructured":"B\u00fcsing KA, Kilian AK, Schaible T, Debus A, Weiss C, Neff KW. Reliability and validity of MR image lung volume measurement in fetuses with congenital diaphragmatic hernia and in vitro lung models. Radiology. 2008;246:553\u201361.","journal-title":"Radiology"},{"key":"2080_CR23","doi-asserted-by":"publisher","first-page":"5339","DOI":"10.1007\/s00330-022-08607-8","volume":"32","author":"Z Han","year":"2022","unstructured":"Han Z, Chen Q, Zhang L, Mo X, You J, Chen L, et al. Radiogenomic association between the T2-FLAIR mismatch sign and IDH mutation status in adult patients with lower-grade gliomas: an updated systematic review and meta-analysis. Eur Radiol. 2022;32:5339\u201352.","journal-title":"Eur Radiol"},{"key":"2080_CR24","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s40478-024-01832-w","volume":"12","author":"I Shin","year":"2024","unstructured":"Shin I, Park YW, Sim Y, Choi SH, Ahn SS, Chang JH, et al. Revisiting gliomatosis cerebri in adult-type diffuse gliomas: a comprehensive imaging, genomic and clinical analysis. Acta Neuropathol Commun. 2024;12:128.","journal-title":"Acta Neuropathol Commun"},{"key":"2080_CR25","doi-asserted-by":"publisher","first-page":"6475","DOI":"10.1007\/s00330-020-07090-3","volume":"30","author":"YW Park","year":"2020","unstructured":"Park YW, Ahn SS, Park CJ, Han K, Kim EH, Kang S-G, et al. Diffusion and perfusion MRI May predict EGFR amplification and the TERT promoter mutation status of IDH-wildtype lower-grade gliomas. Eur Radiol. 2020;30:6475\u201384.","journal-title":"Eur Radiol"},{"key":"2080_CR26","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s00401-018-1905-0","volume":"136","author":"D Stichel","year":"2018","unstructured":"Stichel D, Ebrahimi A, Reuss D, Schrimpf D, Ono T, Shirahata M, et al. Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt Astrocytoma to glioblastoma. Acta Neuropathol. 2018;136:793\u2013803.","journal-title":"Acta Neuropathol"},{"key":"2080_CR27","first-page":"122","volume":"9","author":"MJ Mao","year":"2019","unstructured":"Mao MJ, Leonardi DE. Vascular-endothelial response to IDH1 mutant fibrosarcoma secretome and metabolite: implications on cancer microenvironment. Am J Cancer Res. 2019;9:122\u201333.","journal-title":"Am J Cancer Res"},{"key":"2080_CR28","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1002\/jmri.28589","volume":"58","author":"X Ma","year":"2023","unstructured":"Ma X, Cheng K, Cheng G, Li C, Lyu J, Lan Y, et al. Apparent diffusion coefficient as imaging biomarker for identifying IDH Mutation, 1p19q Codeletion, and MGMT promoter methylation status in patients with glioma. J Magn Reson Imaging. 2023;58:732\u20138.","journal-title":"J Magn Reson Imaging"},{"key":"2080_CR29","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s00428-017-2181-4","volume":"471","author":"SP Ferris","year":"2017","unstructured":"Ferris SP, Hofmann JW, Solomon DA, Perry A. Characterization of gliomas: from morphology to molecules. Virchows Arch. 2017;471:257\u201369.","journal-title":"Virchows Arch"},{"key":"2080_CR30","doi-asserted-by":"publisher","first-page":"e56328","DOI":"10.1371\/journal.pone.0056328","volume":"8","author":"S Popov","year":"2013","unstructured":"Popov S, Jury A, Laxton R, Doey L, Kandasamy N, Al-Sarraj S, et al. IDH1-associated primary glioblastoma in young adults displays differential patterns of tumour and vascular morphology. PLoS ONE. 2013;8:e56328.","journal-title":"PLoS ONE"},{"key":"2080_CR31","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1093\/neuonc\/nos258","volume":"14","author":"J Lazovic","year":"2012","unstructured":"Lazovic J, Soto H, Piccioni D, Lo Ru JR, Li S, Mirsadraei L, et al. Detection of 2-hydroxyglutaric acid in vivo by proton magnetic resonance spectroscopy in U87 glioma cells overexpressing isocitrate dehydrogenase\u20131 mutation. Neuro Oncol. 2012;14:1465\u201372.","journal-title":"Neuro Oncol"},{"key":"2080_CR32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s11060-017-2506-9","volume":"134","author":"K Leu","year":"2017","unstructured":"Leu K, Ott GA, Lai A, Nghiemphu PL, Pope WB, Yong WH, et al. Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II-III diffuse gliomas. J Neurooncol. 2017;134:177\u201388.","journal-title":"J Neurooncol"},{"key":"2080_CR33","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1038\/s41467-021-22543-z","volume":"12","author":"M Udugama","year":"2021","unstructured":"Udugama M, Hii L, Garvie A, Cervini M, Vinod B, Chan F-L, et al. Mutations inhibiting KDM4B drive ALT activation in ATRX-mutated glioblastomas. Nat Commun. 2021;12:2584.","journal-title":"Nat Commun"},{"key":"2080_CR34","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.3390\/cancers15041042","volume":"15","author":"V Di Nunno","year":"2023","unstructured":"Di Nunno V, Aprile M, Gatto L, Tosoni A, Ranieri L, Bartolini S, et al. Tumor microenvironment in gliomas: A treatment hurdle or an opportunity to grab? Cancers (Basel). 2023;15:1042.","journal-title":"Cancers (Basel)"},{"key":"2080_CR35","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s11060-022-04114-4","volume":"159","author":"M Kim","year":"2022","unstructured":"Kim M, Kim S, Park YW, Han K, Ahn SS, Moon JH, et al. Sex as a prognostic factor in adult-type diffuse gliomas: an integrated clinical and molecular analysis according to the 2021 WHO classification. J Neurooncol. 2022;159:695\u2013703.","journal-title":"J Neurooncol"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-02080-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-025-02080-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-02080-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:23:21Z","timestamp":1767054201000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12880-025-02080-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2080"],"URL":"https:\/\/doi.org\/10.1186\/s12880-025-02080-7","relation":{},"ISSN":["1471-2342"],"issn-type":[{"type":"electronic","value":"1471-2342"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"12 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethical Review Committee of The Second Hospital of Shandong University (Approval No. KYLL2024990). The requirement for informed consent was waived. All procedures were carried out in accordance with the relevant guidelines and regulations, and the study was conducted in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"524"}}